FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approves a supplemental application for PROTONIX I.V., authorizing the intravenous form of pantoprazole sodium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• PROTONIX I.V. (pantoprazole sodium)

Snippet

SUPPL AP for PROTONIX I.V. (PANTOPRAZOLE SODIUM)